Checchi Capital Advisers’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $188K | Buy |
12,136
+224
| +2% | +$3.46K | 0.01% | 555 |
|
|
2025
Q1 | $177K | Buy |
+11,912
| New | +$177K | 0.01% | 562 |
|
|
2024
Q1 | – | Sell |
-12,746
| Closed | -$182K | – | 588 |
|
|
2023
Q4 | $182K | Sell |
12,746
-3,377
| -21% | -$48.2K | 0.01% | 534 |
|
|
2023
Q3 | $249K | Buy |
16,123
+1,633
| +11% | +$25.3K | 0.02% | 446 |
|
|
2023
Q2 | $228K | Buy |
14,490
+758
| +6% | +$11.9K | 0.02% | 501 |
|
|
2023
Q1 | $226K | Sell |
13,732
-41
| -0.3% | -$676 | 0.02% | 501 |
|
|
2022
Q4 | $215K | Sell |
13,773
-136
| -1% | -$2.12K | 0.02% | 500 |
|
|
2022
Q3 | $180K | Buy |
13,909
+495
| +4% | +$6.41K | 0.02% | 518 |
|
|
2022
Q2 | $196K | Buy |
13,414
+447
| +3% | +$6.53K | 0.02% | 553 |
|
|
2022
Q1 | $186K | Buy |
12,967
+1,518
| +13% | +$21.8K | 0.02% | 525 |
|
|
2021
Q4 | $156K | Sell |
11,449
-5,614
| -33% | -$76.5K | 0.01% | 517 |
|
|
2021
Q3 | $279K | Buy |
17,063
+26
| +0.2% | +$425 | 0.03% | 381 |
|
|
2021
Q2 | $287K | Sell |
17,037
-285
| -2% | -$4.8K | 0.03% | 380 |
|
|
2021
Q1 | $316K | Buy |
17,322
+13
| +0.1% | +$237 | 0.03% | 332 |
|
|
2020
Q4 | $315K | Sell |
17,309
-2,733
| -14% | -$49.7K | 0.03% | 316 |
|
|
2020
Q3 | $358K | Sell |
20,042
-537
| -3% | -$9.59K | 0.04% | 256 |
|
|
2020
Q2 | $369K | Buy |
20,579
+937
| +5% | +$16.8K | 0.04% | 250 |
|
|
2020
Q1 | $298K | Buy |
19,642
+1,175
| +6% | +$17.8K | 0.03% | 243 |
|
|
2019
Q4 | $364K | Buy |
18,467
+3,990
| +28% | +$78.6K | 0.05% | 252 |
|
|
2019
Q3 | $249K | Buy |
14,477
+547
| +4% | +$9.41K | 0.03% | 330 |
|
|
2019
Q2 | $247K | Sell |
13,930
-2,302
| -14% | -$40.8K | 0.03% | 334 |
|
|
2019
Q1 | $331K | Buy |
+16,232
| New | +$331K | 0.04% | 261 |
|